Literature DB >> 75689

Orally administered prajmalium bitartrate in acute and chronic ventricular arrhythmias.

W D Bussmann, E Müller, H J Hänel, M Kaltenbach.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 75689     DOI: 10.1016/0002-9149(78)90018-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  7 in total

Review 1.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

2.  Pharmacokinetics of N-propylajmaline in relation to polymorphic sparteine oxidation.

Authors:  C Zekorn; G Achtert; H J Hausleiter; C H Moon; M Eichelbaum
Journal:  Klin Wochenschr       Date:  1985-11-15

3.  Cholestatic jaundice: an immune response to prajmalium bitartrate.

Authors:  H H Rotmensch; M Liron; I Yust; A Klejman; E Livni; T Moalem; A Gefel
Journal:  Postgrad Med J       Date:  1980-10       Impact factor: 2.401

4.  [Pharmacokinetics and biotransformation of N-propylajmaline hydrogen tartrate in man].

Authors:  H J Hausleiter; G Achtert; M A Khan; W R Kukovetz; E Beubler
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Oct-Dec       Impact factor: 2.441

5.  Acute haemodynamic effects of ajmaline and prajmaline in patients with coronary heart disease.

Authors:  E Sowton; I D Sullivan; J C Crick
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Prajmalium bitartrate in chronic ventricular arrhythmias: comparison with disopyramide.

Authors:  M Chiariello; C Indolfi; M Cappelli Bigazzi; M Condorelli
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Effects of oral prajmaline bitartrate on exercise test responses in patients with coronary artery disease.

Authors:  C E Handler; A Kritikos; I D Sullivan; A Charalambakis; E Sowton
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.